Systems pharmacology for acute myeloid leukemia and feedback control pharmacodynamic models 

Targeting tumor cells and microvessels in pediatric brain tumors 

Immune signature of murine solid tumor models 

Conjugation of CpG oligodeoxynucleotides to tumor‐targeting antibodies for immunotherapy of solid tumors 

Roles of epithelial-mesenchymal transition and niche in tumorigenesis of tumor-initiating cells 

Bone marrow derived mesenchymal stem cells promote survival and drug resistance in tumor cells 

The role of tumor angiogenesis in glioblastoma multiforme and implications for anticancer therapy 

Identification and characterization of immune-escape mechanisms in solid tumors 

Engineering chimeric antigen receptor-directed immune cells for enhanced antitumor efficacy in solid tumors 

Novel design and combinatory therapy to enhance chimeric antigen receptor engineered T cells (CAR-T) efficacy against solid tumor 

Investigation into the use of repurposed influenza vaccines for immunotherapy of HPV-induced tumors 

Establishing a human EGFR expressing murine mammary carcinoma cell line-D2F2, as a syngeneic immunocompetent model 

Oncolytic adenovirus based vaccine in cancer immunotherapy 

Bone marrow-derived mesenchymal stromal cells in the tumor microenvironment of neuroblastoma 

Investigating the complexity of the tumor microenvironment's role in drug response 

Role of a novel transmembrane protein, MTTS1 in mitochondrial regulation and tumor suppression 

Human myeloid-derived suppressor cells in cancer: Induction, functional characterization, and therapy 

Tri-specific T cell engager immunotherapy targeting tumor initiating cells 

Identification of the targets required for the anti-tumor effect of celecoxib and its non-COX-2 inhibitory derivative 

Improving antitumor efficacy of chimeric antigen receptor-engineered immune cell therapy with synthetic biology and combination therapy approaches 

Engineering immunotoxin and viral vectors for cancer therapy 

Targeting vessel maturation: an anti-angiogenesis based cancer therapy 

Heterogeneity and plasticity of malignant and non-malignant circulating analytes in breast carcinomas 

Steatosis induces Wnt/β-catenin pathway to stimulate proliferation of hepatic tumor initiating cells and promote liver cancer development 

In vivo study with a novel liposomal formulation of a recombinant ADAM disintegrin-like domain showing both anti-angiogenic and tumor growth inhibition activities